FDA Warning Letter — Delux IV and Aesthetics
The FDA took a Warning Letter action against Delux IV and Aesthetics on February 20, 2026 (Beaverton, OR). The action was issued by CDER and concerns drugs products.
Action Details
- Facility
- Delux IV and Aesthetics
- Date
- February 20, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Center
- CDER
- Location
- Beaverton, OR (United States)